Anti-Black bias has been the subject of #blm protests all year - now, sociologists have analysed 4.8 million adults to further explore the current status of police racism.
Tanya Sinclair, Policy Director UK & Ireland at ChargePoint, discusses what the 2021 budget announcement means for consumers and businesses regarding EVs, and how to apply and gain access to the subsidies from a business and personal perspective.
Alison King, CTS’s account manager for the public sector, discusses why Government needs to make modernisation a core focus in 2021, applying the lessons learned in the importance of data during the pandemic.
Nick Smee, CEO of Yotta, explores the digital resident demands and funding issues that councils face may this year and considers the steps they can to take re-evaluate their technology investments, reduce operational costs and better manage budget allocation.
According to HSJ, Health Secretary Matt Hancock's family-owned company were awarded an NHS contract for services - but the Secretary failed to declare any connection to Topwood Ltd.
International child protection groups are speaking out about leaked plans for Facebook to create an "Instagram for children" - a separate version of the app, which would target children under the age of 13.
Dean Billington, Chief Operating Officer at Brains Bioceutical, discusses the pivotal role of the life science sector in spearheading the post-Covid economic recovery and why driving forward R&D and innovation should be the nation’s top priority.
The time has come for online education providers to become accredited by the British Government, says David McCarthy, Director of Education at Sophia Technologies.
Today (8 April) it was revealed that over 700,000 AstraZeneca doses manufactured in the UK are being sent to Australia - with a confirmed 300,000 vaccines in Sydney at the end of February.
New data from the REACT study finds that the prevalence of COVID is down by 60% in one month, but primary school children have the highest COVID infection levels.
The UK's medical authorities cleared continued use of AstraZeneca, but say that 18-29 year olds should take an alternative vaccine to AstraZeneca if possible.
